retatrutide type 2 diabetes trial results 28.7% Weight Loss in New Study – Dr Brad Stanfield 🚨Breaking: Retatrutide's first Phase 3

doi: 10.1056/NEJMoa2505669

Physical activity amplifies retatrutide results by preserving muscle mass during weight loss (critical for maintaining metabolic rate), increasing the caloric deficit beyond what appetite suppression alone achieves, and improving insulin sensitivity, which supports the metabolic effects of the medication

Tirzepatide, for instance, stands out by targeting not only the GLP-1 receptor but also the glucose-dependent insulinotropic polypeptide (GIP) receptor, offering a dual mechanism of action

A role for PPAR- in the control of Gipr gene expression has previously been reported in studies of INS(832/13) cells

Many diabetes patients qualify for medical exemption certificates, making prescriptions free in England as well

Mike Haney: So is it in a way sort of then creating a new settling point if we like that sort of term for where your body wants to be